PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

1.290

+0.100 (8.40%)

Apr 24, 2025, 4:00 PM EDT - Market closed

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 24, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2015 - 2019
Market Capitalization	8	18	51	48	42	36	Upgrade
Market Cap Growth	-40.73%	-64.81%	5.50%	14.27%	16.41%	-21.44%	Upgrade
Enterprise Value	-8	-20	-22	-38	39	36	Upgrade
Last Close Price	1.21	2.12	2.92	2.33	26.57	36.75	Upgrade
PB Ratio	0.21	0.40	0.70	0.54	6.33	7.13	Upgrade
P/TBV Ratio	0.22	0.69	0.74	0.56	13.50	23.58	Upgrade
Debt / Equity Ratio	-	-	-	-	0.01	0.04	Upgrade
Quick Ratio	14.03	31.60	115.99	121.24	3.04	0.87	Upgrade
Current Ratio	14.20	31.76	116.18	121.38	3.14	1.01	Upgrade
Return on Equity (ROE)	42.89%	0.57%	-5.31%	-8.78%	-60.35%	-75.57%	Upgrade
Return on Assets (ROA)	-4.89%	-6.12%	-4.92%	-5.60%	-33.37%	-40.03%	Upgrade
Return on Capital (ROIC)	-5.96%	-6.90%	-4.96%	-5.68%	-37.71%	-46.36%	Upgrade
Earnings Yield	119.62%	1.86%	-8.47%	-8.78%	-8.40%	-10.54%	Upgrade
Buyback Yield / Dilution	35.50%	50.84%	-25.56%	-971.73%	-60.24%	-23.23%	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q